Stockscreener 앱 받기
308.44
5.12%
15.03
Madrigal Pharmaceuticals Inc 주식(MDGL)의 최신 뉴스
Geode Capital Management LLC Boosts Stock Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
9,031 Shares in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Acquired by Wellington Management Group LLP - MarketBeat
Madrigal Pharmaceuticals, Inc.'s (NASDAQ:MDGL) Profit Outlook - Yahoo Finance
FDA Tracker: FDA Hands Out Atopic Dermatitis Approvals to Galderma, Organon - BioSpace
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Bought by Barclays PLC - MarketBeat
Madrigal Pharmaceuticals' SWOT analysis: rezdiffra launch key to stock's future - Investing.com
Y Intercept Hong Kong Ltd Takes Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
How To Trade (MDGL) - Stock Traders Daily
State Street Corp Increases Stock Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Brokerages Set Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) PT at $347.33 - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $4.74 Million Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Madrigal Pharmaceuticals' SWOT analysis: rezdiffra's potential drives stock outlook - Investing.com India
Madrigal Pharmaceuticals' SWOT analysis: rezdiffra's potential drives stock outlook By Investing.com - Investing.com Australia
XTX Topco Ltd Invests $1.04 Million in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Madrigal (MDGL) Just Flashed Golden Cross Signal: Do You Buy? - MSN
BNP Paribas Financial Markets Has $2.07 Million Stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Madrigal Pharmaceuticals price target raised to $427 from $415 at JMP Securities - Yahoo Finance
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock Position Lessened by The Manufacturers Life Insurance Company - MarketBeat
Madrigal Pharmaceuticals (LTS:0JXI) 9-Day RSI : 50.46 (As of Dec. 05, 2024) - GuruFocus.com
Madrigal Pharmaceuticals director Fred Craves sells shares worth $1.14 million - Investing.com
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) is RTW Investments LP's Largest Position - MarketBeat
How to Take Advantage of moves in (MDGL) - Stock Traders Daily
Cinctive Capital Management LP Makes New Investment in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
When Will Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Breakeven? - Simply Wall St
Charles Schwab Investment Management Inc. Boosts Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Fmr LLC Sells 5,458 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or More - AOL
Martingale Asset Management L P Takes Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Madrigal Pharmaceuticals (FRA:YDO1) 9-Day RSI : 56.49 (As of Dec. 01, 2024) - GuruFocus.com
Madrigal Pharmaceuticals (FRA:YDO1) Total Assets : €967.01 Mil (As of Sep. 2024) - GuruFocus.com
Erste Asset Management GmbH Makes New $49.75 Million Investment in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Braidwell LP Takes $39.01 Million Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
MDGL (Madrigal Pharmaceuticals) EBITDA : $-502.65 Mil (TTM As of Sep. 2024) - GuruFocus.com
Vestal Point Capital LP Buys New Shares in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
1,852 Shares in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Purchased by Blueshift Asset Management LLC - MarketBeat
MDGL (Madrigal Pharmaceuticals) Shares Outstanding (EOP) : 21.81 Mil (As of Sep. 2024) - GuruFocus.com
Advantage Alpha Capital Partners LP Makes New $349,000 Investment in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Intech Investment Management LLC Takes $1.28 Million Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Madrigal Pharmaceuticals (LTS:0JXI) Total Stockholders Equi - GuruFocus.com
3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise Move - MSN
Eagle Asset Management Inc. Makes New Investment in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
MDGL (Madrigal Pharmaceuticals) Total Inventories : $8.72 Mil (As of Sep. 2024) - GuruFocus.com
When (MDGL) Moves Investors should Listen - Stock Traders Daily
Non-alcoholic Steatohepatitis (NASH) Treatment Market 2032: Clinical Trials, Medication, EMA, PDMA, FDA Approvals, Epidemiology, Therapies, Companies by DelveInsight - The Globe and Mail
Novo semaglutide data in MASH could negatively impact Madrigal's Rezdiffra - MSN
Why Is Madrigal Pharmaceuticals, Inc. (MDGL) Among the Worst Performing Biotech Stocks in 2024? - Insider Monkey
Madrigal Pharmaceuticals Engages with Investors at Key Conferences - MSN
Connor Clark & Lunn Investment Management Ltd. Decreases Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Madrigal shares hold as Cowen maintains price target on new data - Investing.com Canada
Madrigal Pharmaceuticals (FRA:YDO1) Peter Lynch Fair Value : N/A (As of Nov. 20, 2024) - GuruFocus.com
Novo semaglutide data in MASH could negatively impact Madrigal's Rezdiffra (MDGL:NASDAQ) - Seeking Alpha
2.88%
2.65%
자본화:
|
볼륨(24시간):